Modulation of osteoclastogenesis by fatty acids

Endocrinology

Volumn 149, Issue 11, 2008, Pages 5688-5695

  Cornish, Jillian ^a   MacGibbon, Alastair ^b   Lin, Jian Ming ^a   Watson, Maureen ^a   Callon, Karen E ^a   Tong, P C ^a   Dunford, James E ^c   Van Der Does, Yvonne ^b   Williams, Garry A ^a   Grey, Andrew B ^a   Naot, Dorit ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FONTERRA RESEARCH CENTRE   (New Zealand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MEVALONIC ACID; MILK FAT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW; BONE MARROW CULTURE; CALVARIA; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; MALE; NONHUMAN; OBESITY; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; RAT;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FATTY ACIDS; MACROPHAGES; MALE; MEVALONIC ACID; MICE; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RATS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 54349086815     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0111     Document Type: Article

References (23)

1. Reid IR 2002 Relationships among body mass, its components, and bone. Bone 31:547-555
2. Reid IR 2008 Relationships between fat and bone. Osteoporosis International 19:595-606
3. Reid IR, Cornish J, Baldock PA 2006 Nutrition-related peptides and bone homeostasis. J Bone Miner Res 21:495-500
4. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EEG, Byrjalsen I, Krarup T, Holst JJ, Christiansen C 2003 Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18:2180-2189
5. Priante G, Bordin L, Musacchio E, Clari G, Baggio B 2002 Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci 102:403-409
6. Watkins BA, Li Y, Lippman HE, Feng S 2003 Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 68:387-398
7. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, Watson M, Lin JM, Tong PC, Chen Q, Chan VA, Reid HE, Fazzalari N, Baker HM, Baker EN, Haggarty NW, Grey AB, Reid IR 2004 Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145:4366-4374
8. MacGibbon AKH, Taylor MW 2006 Composition and structure of bovine milk lipids. In: Fox PF, McSweeney PLH, eds. Advanced dairy chemistry. 3rd ed. New York: Springer; 1-43
9. Milligan G, Stoddart LA, Brown AJ 2006 G protein-coupled receptors for free fatty acids. Cell Signal 18:1360-1365
10. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94
11. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M 2003 Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 422:173-176
12. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ 2003 The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312-11319
13. Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Cooper GJ, Reid IR 1999 Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol 277:E779-E783
14. Khosla S 2001 Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050-5055
15. Kavanagh KL, Dunford JE, Bunkoczi G, Russell RGG, Oppermann U 2006 The crystal structure of human geranylgeranyl pyrophosphate synthase reveals a novel hexameric arrangement and inhibitory product binding. J Biol Chem 281:22004-22012
16. Kavanagh KL, Guo KD, Dunford JE, Wu XQ, Knapp S, Ebetino FH, Rogers MJ, Russell RGG, Oppermann U 2006 The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs. Proc Natl Acad Sci USA 103:7829-7834
17. Thompson K, Kikuvi T, Rogers M 2006 Alkylamines prevent osteoclast formation and activity by inhibiting the mevalonate pathway. Bone 38(Suppl):S31
18. Reed BC, Rilling HC 1976 Substrate binding of avian liver prenyltransferase. Biochemistry 15:3739-3745
19. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR, McCoy DC, Kenakin TP, Andrews JL, Ammala C, Fornwald JA, Ignar DM, Jenkinson S 2006 Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 148:619-628
20. Ihle R, Loucks AB 2004 Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res 19:1231-1240
21. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R 2002 Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30:886-890
22. Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C 2002 Mechanism of circadian variation in bone resorption. Bone 30:307-313
23. Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H 2000 Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 17:124-129